Epidermal growth factor receptor mutations should be considered as a prognostic factor for survival of patients with pathological fractures or painful bone metastases from non-small cell lung cancer
J. J. Willeumier, N. M.A. Van Der Hoeven, L. Bollen, L. N.A. Willems, M. Fiocco, Y. M. Van Der Linden, P. D.S. Dijkstra
Research output: Contribution to journal › Article › peer-review
10Citations
(Scopus)
Fingerprint
Dive into the research topics of 'Epidermal growth factor receptor mutations should be considered as a prognostic factor for survival of patients with pathological fractures or painful bone metastases from non-small cell lung cancer'. Together they form a unique fingerprint.